US FDA Approved Novel Drugs for Year 2020

US FDA Approved Novel Drugs for Year 2020

Find the list of Approved new drug ingredient which are approved by US FDA in year 2020

No. Active Ingredient FDA-approved use on approval date* Approval Date
1 Vibegron To treat overactive bladder 12/23/2020
 
2 Ansuvimab-zykl To treat ebola 12/21/2020
 
3 Relugolix To treat advanced prostate cancer 12/18/2020
4 Margetuximab (anti-HER2 mAb To treat HER2+ breast cancer 12/16/2020
5 Tirbanibulin To treat actinic Keratosis of the face or scalp 12/14/2020
6 Berotralstat To treat patients with hereditary angioedema 12-03-2020
7 Gallium 68 PSMA-11 For detection and localization of prostate cancer 12-01-2020
8 Naxitamab-gqgk To treat high-risk refractory or relapsed neuroblastoma 11/25/2020
9 Setmelanotide To treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency, a rare disorder that causes severe obesity that begins at an early age 11/25/2020
10 Lumasiran To treat hyperoxaluria type 1 11/23/2020
11 Lonafarnib To treat rare conditions related to premature aging 11/20/2020
12 Remdesivir To treat COVID-19 10/22/2020
13 Atoltivimab, Maftivimab, and Odesivimab-ebgn To treat ebola virus 10/14/2020
14 Pralsetinib To treat non-small lung cancer 09-04-2020
15 Copper Cu 64 dotatate injection To help detect certain types of neuroendocrine tumors 09-03-2020
16 Somapacitan-beco Growth hormone 8/28/2020
17 Clascoterone To treat acne 8/26/2020
18 Satralizumab-mwge To treat neuromyelitis optica spectrum disorder 8/14/2020
19 Viltolarsen To treat Duchenne muscular dystrophy 08-12-2020
20 Oliceridine To manage acute pain in certain adults 08-07-2020
21 Risdiplam To treat spinal muscular atrophy 08-07-2020
22 Nifurtimox To treat Chagas disease in certain pediatric patients younger than age 18 08-06-2020
23 Belantamab mafodotin-blmf To treat multiple myeloma 08-05-2020
24 Tafasitamab-cxix To treat relapsed or refractory diffuse large B-cell lymphoma 7/31/2020
25 Abametapir To treat head lice 7/24/2020
26 Decitabine and Cedazuridine To treat adult patients with myelodysplastic syndromes 07-07-2020
27 Fostemsavir To treat HIV 07-02-2020
28 Remimazolam For sedation 07-02-2020
29 Triheptanoin To treat molecularly long-chain fatty acid oxidation disorders 6/30/2020
30 Lurbinectedin To treat metastatic small cell lung cancer 6/15/2020
31 Inebilizumab-cdon To treat neuromyelitis optica spectrum disorder 06-11-2020
32 Flortaucipir F18 Diagnostic agent for patients with Alzheimer’s disease 5/28/2020
33 Artesunate To treat severe malaria 5/26/2020
34 Fluoroestradiol F18 Diagnostic imaging agent for certain patients with breast cancer 5/20/2020
35 Ripretinib To treat advanced gastrointestinal-stromal tumors 5/15/2020
36 Selpercatinib To treat lung and thyroid cancers 05-08-2020
37 Capmatinib To treat patients with non small cell lung cancer 05-06-2020
38 Opicapone To treat patients with Parkinson’s disease experiencing “off” episodes 4/24/2020
39 Sacituzumab govitecan-hziy To treat adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease 4/22/2020
40 Pemigatinib To treat certain patients with cholangiocarcinoma, a rare form of cancer that forms in bile ducts 4/17/2020
41 Tucatinib To treat advanced unresectable or metastatic HER2-positive breast cancer 4/17/2020
42 Selumetinib To treat neurofibromatosis type 1, a genetic disorder of the nervous system causing tumors to grow on nerves 04-10-2020
43 Ozanimod To treat relapsing forms of multiple sclerosis 3/25/2020
44 Osilodrostat To treat adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease 03-06-2020
45 Isatuximab To treat multiple myloma 03-02-2020
46 Rimegepant To treat migraine 2/27/2020
47 Amisulpride To help prevent nausea and vomiting after surgery 2/26/2020
48 Eptinezumab-jjmr For the preventive treatment of migraine in adults 2/21/2020
49 Bempedoic acid To treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C 2/21/2020
50 Lactitol To treat chronic idiopathic constipation (CIC) in adults 02-12-2020
51 Tazemetostat To treat epithelioid sarcoma 1/23/2020
52 Teprotumumab-trbw To treat Thyroid eye disease 1/21/2020
53 Avapritinib To treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) 01-09-2020

Leave a Reply

Your email address will not be published. Required fields are marked *

17 − 5 =

×
Free Video Lectures of Pharmacy Exams
Apply now

Developed By Connect Globes